Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Elihu Estey"'
Autor:
Laura Cicconi, Anna Maria Testi, Pau Montesinos, Eduardo Rego, Hong Hu Zhu, Hiroyuki Takahashi, Michael Dworzak, Elihu Estey, Anthony Schwarer, Jordi Esteve, Ombretta Annibali, Roberto Castelli, Milena Mirabile, Mario Angelini, Vladimir Lazarevic, Jeevan Kumar, Giuseppe Avvisati, Carmelo Gurnari, Franco Locatelli, Maria Teresa Voso, Miguel Angel Sanz, Francesco Lo-Coco, Oussama Abla
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/952825a19cbd4a4cadc9a98a15926e56
Autor:
Johann Hitzler, Elihu Estey
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/a74ec890057a402c8ffc71815ecef259
Autor:
Megan Othus, Wim van Putten, Bob Lowenberg, Stephen H. Petersdorf, Sucha Nand, Harry Erba, Frederick Appelbaum, Robert Hills, Nigel Russell, Alan Burnett, Elihu Estey
Publikováno v:
Haematologica, Vol 101, Iss 7 (2016)
Externí odkaz:
https://doaj.org/article/65d96c3113124264b2e5d631f352f7b8
Autor:
Elihu Estey
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 5, Iss 1, Pp e2013050-e2013050 (2013)
Although “less intense” therapies are finding more use in AML, the principal problem in AML remains lack of efficacy rather than toxicity. Hence less intense therapies are of little use if they are not more effective as well as less toxic than st
Externí odkaz:
https://doaj.org/article/14b77e65b99d41a9bc1d9a08dd9a86d7
Autor:
Elihu Estey
Publikováno v:
Haematologica, Vol 94, Iss 10 (2009)
This paper contends that commonly used clinical trial designs do not reflect clinical reality as viewed by patients or physicians. Specifically, randomized phase III designs focus on improvements that are more significant statistically than medically
Externí odkaz:
https://doaj.org/article/05fd8f610f8247d78f6d1bdf39b61197
Autor:
Masamitsu Yanada, Gautam Borthakur, Farhad Ravandi, Carlos Bueso-Ramos, Hagop Kantarjian, Elihu Estey
Publikováno v:
Haematologica, Vol 93, Iss 8 (2008)
Externí odkaz:
https://doaj.org/article/5d92adc8a7384a35bd71079b4efed827
Autor:
Masamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, Farhad Ravandi, Hagop Kantarjian, Elihu Estey
Publikováno v:
Haematologica, Vol 93, Iss 4 (2008)
Externí odkaz:
https://doaj.org/article/305b9e33f05347c2a65d4c32b9f22e7a
Autor:
Maher Albitar, Francis Giles, Michael Keating, Jorge Cortes, Zeev Estrov, Elihu Estey, Susan O'Brien, Zhong J. Zhang, Xi Zhang, Amber C. Donahue, Benjamin Bekele, Hagop Kantarjian, Wanlong Ma
Purpose: Cytogenetic abnormalities are currently the most important predictors of response and clinical outcome for patients with acute myeloid leukemia (AML) or advanced-stage myelodysplastic syndrome (MDS). Because clinical outcomes vary markedly w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f9a71c46b0fc1335d27e5216c074be
https://doi.org/10.1158/1078-0432.c.6517486.v1
https://doi.org/10.1158/1078-0432.c.6517486.v1
Autor:
Jean-Pierre J. Issa, Guillermo Garcia-Manero, Hagop Kantarjian, Elihu Estey, Kazuo Konishi, Vazganush Gharibyan, Lanlan Shen, Xuqi Chen, Yutaka Kondo, Yanis A. Boumber
Gene silencing associated with promoter methylation can inactivate tumor suppressor genes (TSG) in cancer. We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7872cd95bf485fe2d34f01f892c9bcc3
https://doi.org/10.1158/0008-5472.c.6495164
https://doi.org/10.1158/0008-5472.c.6495164
Autor:
Jean-Pierre J. Issa, Guillermo Garcia-Manero, Hagop Kantarjian, Elihu Estey, Kazuo Konishi, Vazganush Gharibyan, Lanlan Shen, Xuqi Chen, Yutaka Kondo, Yanis A. Boumber
Supplementary Table 1 from RIL, a LIM Gene on 5q31, Is Silenced by Methylation in Cancer and Sensitizes Cancer Cells to Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5bbd90980d7e2071e128205ff23100
https://doi.org/10.1158/0008-5472.22366496.v1
https://doi.org/10.1158/0008-5472.22366496.v1